Treatment

Port Delivery System with Ranibizumab clinical trials

2 indexed studies · 0 currently recruiting

Active not recruiting
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
This study looks at how well certain eye medicines from Roche work for conditions like wet macular degeneration and diabetic eye disease in real patients. It's about understanding long-term results and why doctors choose specific treatments, without changing how patients are usually cared for.
For: Neovascular Age-related Macular Degeneration · Diabetic Macular Edema · Retinal Vein Occlusion
United States · Argentina · Australia
Active not recruitingPHASE3
A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)
This study looks at a new way to treat a common eye condition called 'wet' Age-related Macular Degeneration (nAMD). It tests how well a special eye implant works, which slowly releases medicine over a long time, compared to standard eye injections.
For: Neovascular Age-related Macular Degeneration (nAMD)
Argentina · Australia · Austria